MyFinsight
Home
Blog
About
Contact
Proceeds from maturities
and sales of...
$10,000K
Proceeds from exercise of
stock options
$22K
Net cash provided by
(used in) investing...
$8,985K
Net cash provided by
financing activities
$20K
Canceled cashflow
$1,015K
Canceled cashflow
$2K
Net increase in cash
and cash...
$231K
Canceled cashflow
$8,774K
Purchases of marketable
securities
$1,007K
Purchases of property and
equipment
$8K
Stock-based compensation
$835K
Depreciation and
amortization
$193K
Non-cash lease expense
$67K
Non-cash investment
income, net
-$6K
Accounts receivable
-$1K
Finance lease principal
payments
$2K
Net cash used in
operating activities
-$8,774K
Canceled cashflow
$1,102K
Other income, net
$963K
Net loss
-$8,399K
Prepaid expenses and
other assets
$1,270K
Canceled cashflow
$963K
Accrued and other
current liabilities
-$116K
Accounts payable
-$70K
Other
$16K
Deferred revenue
-$5K
Revenue
$14K
Loss from operations
-$9,360K
Canceled cashflow
$14K
Interest expense
$2K
Payroll related
expenses
$4,598K
Consulting and
professional fees
$1,923K
Other segment items
$1,377K
Stock-based compensation
expense
$835K
Equipment, lab supplies,
and facility...
$313K
Depreciation and
amortization
$164K
Clinical studies and
outside processing
$122K
Cost of revenue
$42K
Back
Back
Cash Flow
SERA PROGNOSTICS, INC. (SERA)
SERA PROGNOSTICS, INC. (SERA)
source: myfinsight.com